These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25010828)

  • 21. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.
    Liang D; Gao Y; Lin X; He Z; Zhao Q; Deng Q; Lan K
    Cell Res; 2011 May; 21(5):793-806. PubMed ID: 21221132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cells.
    Yang Y; Boss IW; McIntyre LM; Renne R
    BMC Genomics; 2014 Aug; 15(1):668. PubMed ID: 25106478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
    Sadagopan S; Sharma-Walia N; Veettil MV; Raghu H; Sivakumar R; Bottero V; Chandran B
    J Virol; 2007 Apr; 81(8):3949-68. PubMed ID: 17287275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
    Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
    J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms.
    Botto S; Totonchy JE; Gustin JK; Moses AV
    mBio; 2015 Jun; 6(3):e00668. PubMed ID: 26045540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity.
    Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B
    J Virol; 2019 May; 93(9):. PubMed ID: 30787155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release.
    Dollery SJ; Maldonado TD; Brenner EA; Berger EA
    Front Cell Infect Microbiol; 2021; 11():654396. PubMed ID: 33937098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
    Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
    J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.
    Singh VV; Kerur N; Bottero V; Dutta S; Chakraborty S; Ansari MA; Paudel N; Chikoti L; Chandran B
    J Virol; 2013 Apr; 87(8):4417-31. PubMed ID: 23388709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
    Chen M; Sun F; Han L; Qu Z
    Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.
    Lei X; Bai Z; Ye F; Xie J; Kim CG; Huang Y; Gao SJ
    Nat Cell Biol; 2010 Feb; 12(2):193-9. PubMed ID: 20081837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
    Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
    J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.
    Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.
    Yan Q; Li W; Tang Q; Yao S; Lv Z; Feng N; Ma X; Bai Z; Zeng Y; Qin D; Lu C
    PLoS One; 2013; 8(2):e55832. PubMed ID: 23418466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
    An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
    J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
    Punjabi AS; Carroll PA; Chen L; Lagunoff M
    J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.
    Yan Q; Ma X; Shen C; Cao X; Feng N; Qin D; Zeng Y; Zhu J; Gao SJ; Lu C
    J Virol; 2014 May; 88(9):4987-5000. PubMed ID: 24554664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
    Ramalingam D; Happel C; Ziegelbauer JM
    J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.